Impact of the COVID-19 Pandemic on a Cancer Fast-Track Programme

被引:3
作者
Martinez, M. T. [1 ]
Moragon, S. [1 ]
Ortega-Morillo, B. [1 ]
Monton-Bueno, J. [1 ]
Simon, S. [1 ]
Rosello, S. [1 ,2 ,3 ]
Insa, A. [1 ]
Viala, A. [1 ]
Navarro, J. [4 ,5 ]
Sanmartin, A. [4 ]
Fluixa, C. [6 ]
Julve, A. [7 ]
Soriano, D. [7 ]
Buch, E. [8 ]
Pena, A. [9 ]
Franco, J. [10 ]
Martinez-Jabaloyas, J. [11 ]
Marco, J. [12 ]
Forner, M. J. [13 ]
Cano, A. [14 ]
Silvestre, A. [15 ]
Teruel, A. [16 ]
Bermejo, B. [1 ,2 ,3 ]
Cervantes, A. [1 ,2 ,3 ]
Gonzalez, I. Chirivella [1 ]
机构
[1] Univ Valencia, Hosp Clin Univ, Biomed Res Inst INCLIVA, Dept Med Oncol Dept, Valencia, Spain
[2] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Oncol, Av Blasco Ibanez 17, Valencia 46010, Spain
[3] Inst Salud Carlos III, CIBERONC, Madrid, Spain
[4] Univ Valencia, Hosp Clin Univ Valencia, Biomed Res Inst INCLIVA, Management Dept, Valencia, Spain
[5] Inst Salud Carlos III, CIBERESP CIBER Epidemiol & Salud Publ, Ctr Nacl Epidemiol, Madrid, Spain
[6] Alfahuir Primare Care Ctr, Valencia, Spain
[7] Univ Valencia, INCLIVA Biomed Res Inst, Dept Radiodiag, Valencia, Spain
[8] Univ Valencia, INCLIVA Biomed Res Inst, Dept Surg, Valencia, Spain
[9] Univ Valencia, INCLIVA Biomed Res Inst, Dept Med Digest, Valencia, Spain
[10] Univ Valencia, INCLIVA Biomed Res Inst, Dept Pneumol, Valencia, Spain
[11] Univ Valencia, INCLIVA Biomed Res Inst, Dept Urol, Valencia, Spain
[12] Univ Valencia, INCLIVA Biomed Res Inst, Dept Otolaryngol, Valencia, Spain
[13] Univ Valencia, INCLIVA Biomed Res Inst, Dept Internal Med, Valencia, Spain
[14] Univ Valencia, INCLIVA Biomed Res Inst, Dept Gynaecol, Valencia, Spain
[15] Univ Valencia, INCLIVA Biomed Res Inst, Dept Traumatol, Valencia, Spain
[16] Univ Valencia, INCLIVA Biomed Res Inst, Dept Haematol, Valencia, Spain
关键词
cancer; primary care; cancer fast track program; early diagnostic; COVID-19; pandemic; DIAGNOSIS; MANAGEMENT; CARE; ENGLAND;
D O I
10.1177/10732748221131000
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The COVID-19 pandemic has disrupted many aspects of clinical practice in oncology, particularly regarding early cancer diagnosis, sparking public health concerns that possible delays could increase the proportion of patients diagnosed at advanced stages. In 2009, a cancer fast-track program (CFP) was implemented at the Clinico-Malvarrosa Health Department in Valencia, Spain with the aim of shortening waiting times between suspected cancer symptoms, diagnosis and therapy initiation. Objectives: The study aimed to explore the effects of the COVID-19 pandemic on our cancer diagnosis fast-track program. Methods: The program workflow (patients included and time periods) was analysed from the beginning of the state of alarm on March 16th, 2020 until March 15th, 2021. Data was compared with data from the same period of time from the year before (2019). Results: During the pandemic year, 975 suspected cancer cases were submitted to the CFP. The number of submissions only decreased during times of highest COVID-19 incidence and stricter lockdown, and overall, referrals were slightly higher than in the previous 2 years. Cancer diagnosis was confirmed in 197 (24.1%) cases, among which 33% were urological, 23% breast, 16% gastrointestinal and 9% lung cancer. The median time from referral to specialist appointment was 13 days and diagnosis was reached at a median of 18 days. In confirmed cancer cases, treatment was started at around 30 days from time of diagnosis. In total, 61% of cancer disease was detected at early stage, 20% at locally advanced stage, and 19% at advanced stage, displaying time frames and case proportions similar to pre-pandemic years. Conclusions: Our program has been able to maintain normal flow and efficacy despite the challenges of the current pandemic, and has proven a reliable tool to help primary care physicians referring suspected cancer patients.
引用
收藏
页数:10
相关论文
共 33 条
[1]   The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis [J].
Alfano, Vincenzo ;
Ercolano, Salvatore .
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020, 18 (04) :509-517
[2]   General practictioners' management of cancer in England: secondary analysis of data from the National Survey of NHS Patients - Cancer [J].
Allgar, VL ;
Neal, RD .
EUROPEAN JOURNAL OF CANCER CARE, 2005, 14 (05) :409-416
[3]   Impact of the COVID-19 pandemic on the care of cancer patients in Spain [J].
Amador, M. ;
Matias-Guiu, X. ;
Sancho-Pardo, G. ;
Contreras Martinez, J. ;
de la Torre-Montero, J. C. ;
Penuelas Saiz, A. ;
Garrido, P. ;
Garcia-Sanz, R. ;
Rodriguez-Lescure, A. ;
Paz-Ares, L. .
ESMO OPEN, 2021, 6 (03)
[4]  
American Society of Clinical Oncology, PAT CAR INF
[5]   The Italian health system and the COVID-19 challenge [J].
Armocida, Benedetta ;
Formenti, Beatrice ;
Ussai, Silvia ;
Palestra, Francesca ;
Missoni, Eduardo .
LANCET PUBLIC HEALTH, 2020, 5 (05) :E253-E253
[6]  
boe, REAL DECRETO 463 202
[7]   Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology [J].
Castelo-Branco, L. ;
Awada, A. ;
Pentheroudakis, G. ;
Perez-Gracia, J. L. ;
Mateo, J. ;
Curigliano, G. ;
Banerjee, S. ;
Giuliani, R. ;
Lordick, F. ;
Cervantes, A. ;
Tabernero, J. ;
Peters, S. .
ESMO OPEN, 2021, 6 (05)
[8]  
clinicomalvarrosa, MEMORIAS DEP
[9]   The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure [J].
Colivicchi, Furio ;
Di Fusco, Stefania Angela ;
Magnanti, Massimo ;
Cipriani, Manlio ;
Imperoli, Giuseppe .
JOURNAL OF CARDIAC FAILURE, 2020, 26 (06) :464-465
[10]   Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology [J].
De Vincentiis, Ludovica ;
Carr, Richard A. ;
Mariani, Maria Paola ;
Ferrara, Gerardo .
JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (03) :187-189